Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report
ConclusionThe current study suggests that nivolumab may be a viable option for patients with metastatic primary malignant melanoma of the esophagus. Additional evidence from future clinical trials and research is necessary to fully validate these findings.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Cancer & Oncology | Clinical Trials | CT Scan | Esophagectomy | Esophagoscopy | Esophagus Cancer | Gastroenterology | General Medicine | Hypertension | Immunotherapy | Japan Health | Melanoma | Sarcoidosis | Skin Cancer | Study